94 related articles for article (PubMed ID: 22258337)
1. CCR5 deficiency does not reduce hypertensive end-organ damage in mice.
Krebs C; Fraune C; Schmidt-Haupt R; Turner JE; Panzer U; Quang MN; Tannapfel A; Velden J; Stahl RA; Wenzel UO
Am J Hypertens; 2012 Apr; 25(4):479-86. PubMed ID: 22258337
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.
Krebs CF; Lange S; Niemann G; Rosendahl A; Lehners A; Meyer-Schwesinger C; Stahl RA; Benndorf RA; Velden J; Paust HJ; Panzer U; Ehmke H; Wenzel UO
Hypertension; 2014 Mar; 63(3):565-71. PubMed ID: 24366079
[TBL] [Abstract][Full Text] [Related]
3. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
[TBL] [Abstract][Full Text] [Related]
4. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.
Weiss S; Rosendahl A; Czesla D; Meyer-Schwesinger C; Stahl RA; Ehmke H; Kurts C; Zipfel PF; Köhl J; Wenzel UO
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1356-65. PubMed ID: 27053686
[TBL] [Abstract][Full Text] [Related]
5. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
6. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats.
Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071
[TBL] [Abstract][Full Text] [Related]
7. The chemokine receptor CX
Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
9. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II.
Kirchhoff F; Krebs C; Abdulhag UN; Meyer-Schwesinger C; Maas R; Helmchen U; Hilgers KF; Wolf G; Stahl RA; Wenzel U
Kidney Int; 2008 Mar; 73(5):643-50. PubMed ID: 18033241
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice.
Moreno C; Nicaise C; Gustot T; Quertinmont E; Nagy N; Parmentier M; Louis H; Devière J
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1089-99. PubMed ID: 16891300
[TBL] [Abstract][Full Text] [Related]
11. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
[TBL] [Abstract][Full Text] [Related]
12. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.
Shimizu K; Furuichi K; Sakai N; Kitagawa K; Matsushima K; Mukaida N; Kaneko S; Wada T
Hypertens Res; 2011 Jun; 34(6):747-52. PubMed ID: 21451526
[TBL] [Abstract][Full Text] [Related]
16. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension.
Gratze P; Dechend R; Stocker C; Park JK; Feldt S; Shagdarsuren E; Wellner M; Gueler F; Rong S; Gross V; Obst M; Plehm R; Alenina N; Zenclussen A; Titze J; Small K; Yokota Y; Zenke M; Luft FC; Muller DN
Circulation; 2008 May; 117(20):2645-56. PubMed ID: 18474814
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells.
Schreier B; Rabe S; Schneider B; Ruhs S; Grossmann C; Hauptmann S; Blessing M; Neumann J; Gekle M
Hypertens Res; 2011 May; 34(5):623-9. PubMed ID: 21346767
[TBL] [Abstract][Full Text] [Related]
19. CC Chemokine receptor 5 deficiency does not prevent local immune responses to adenovirus vector in islet transplant recipients.
Cheng J; Sung RS
J Surg Res; 2012 May; 174(1):166-75. PubMed ID: 21276984
[TBL] [Abstract][Full Text] [Related]
20. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2008 Nov; 181(9):6546-56. PubMed ID: 18941245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
